Pregnancy and Breastfeeding: These medications are not recommended during pregnancy or while breastfeeding, so consult your doctor if you're planning to conceive
a more favorable option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS Reference: rxlist.com (Tanzeum) Dulaglutide Drug Name: Trulicity (FDA Approved 9/18/14) GLP-1 receptor agonist, hypoglycemic Pharmacokinetics: Long acting (half life: 5 days) subcutaneous pen injections weekly dosing (vs daily dosing for some other GLP-1 agonists such as exenatide, liraglutide & lixisenatide) a more favorable dosing option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
Evidence Boundary: Although A/B-level studies show that this endpoint depends on the microbiota and is related to changes in metabolites, the existing evidence is not enough to determine the direction of barrier repair in the causal chain (upstream drive or downstream accompaniment)
GHK-Cu + Microneedling Microneedling increases scalp blood flow and creates microchannels for deeper product penetration
This produces multiple effects on metabolic pathways: Pancreatic and glycemic control [edit] Semaglutide enhances the growth and proliferation of pancreatic beta cells, which are responsible for insulin production, while mitigating oxidative stress to reduce cell death (apoptosis)
